The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing

BACKGROUND: HER2 status assessment is a prerequisite for the establishment of an appropriate treatment strategy in gastric cancer. Gastric cancers are very heterogeneous and separate evaluations of gene amplification and protein expression lead to uncertainties in localizing distinct clones and are...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Dominique, Battmann, Achim, Steinmetz, Kristina, Jones, Tobin, Lamb, Tiffany, Martinez, Michele, Altmannsberger, Hans-Michael, Al-Batran, Salah-Eddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059883/
https://www.ncbi.nlm.nih.gov/pubmed/24906218
http://dx.doi.org/10.1186/1479-5876-12-160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059883/
https://www.ncbi.nlm.nih.gov/pubmed/24906218
http://dx.doi.org/10.1186/1479-5876-12-160

Ejemplares similares